胃体部连续致癌激活诱导胃癌的小鼠模型研究
本研究利用新型Pgc-CreERT2敲入小鼠模型,追踪表达胃蛋白酶原C(PGC)转录本的细胞在胃体化生和癌变中的细胞起源。研究发现这些细胞主要标记主细胞,也低水平标记颈细胞和峡部干/祖细胞区域;联合KrasG12D、Apc和Trp53激活可依次诱导假幽门化生、黏膜内异型增生/癌和侵袭转移性胃癌。
要点
- Pgc-CreERT2小鼠可追踪主细胞及峡部祖细胞,后者对致癌突变快速增殖应答。
- KrasG12D激活 alone 诱导假幽门化生,联合Apc失活出现黏膜内异型增生/癌。
- 进一步联合Trp53失活可导致侵袭性和转移性胃癌。
核心结论
- 表达PGC转录本的细胞可作为胃体化生和胃癌的细胞起源,连续致癌激活可重现从化生到转移性癌的全过程。
研究设计与样本
- 研究构建Pgc-mCherry-IRES-CreERT2敲入小鼠,并与Rosa-EYFP、KrasG12D、Apcflox、Trp53flox等品系杂交进行谱系追踪和肿瘤发生实验。
主要发现
- Pgc-CreERT2小鼠中mCherry主要标记主细胞,也低水平标记颈细胞和峡部干/祖细胞区域。
- Pgc-CreERT2;KrasG12D/+小鼠出现假幽门化生,峡部早期增殖诱导可能反映峡部祖细胞对KrasG12D突变的快速反应。
- Pgc-CreERT2;KrasG12D/+;Apcflox/flox小鼠出现黏膜内异型增生/癌。
- Pgc-CreERT2;KrasG12D/+;Apcflox/flox;Trp53flox/flox小鼠出现侵袭性和转移性胃癌。
临床怎么用
- 该模型可用于研究胃体部致癌打击下峡部细胞和主细胞的时序反应,以及胃特异性肿瘤从发生到转移的过程。
局限性
- 研究基于小鼠模型,结果外推到人类胃 carcinogenesis 需谨慎验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Metaplasia and dysplasia in the corpus are reportedly derived from de-differentiation of chief cells. However, the cellular origin of metaplasia and cancer remained uncertain. Therefore, we investigated whether pepsinogen C (PGC) transcript-expressing cells represent the cellular origin of metaplasia and cancer using a novel Pgc-specific CreERT2 recombinase mouse model. METHODS: We generated a Pgc-mCherry-IRES-CreERT2 (Pgc-CreERT2) knock-in mouse model. Pgc-CreERT2/+ and Rosa-EYFP mice were crossed to generate Pgc-CreERT2/Rosa-EYFP (Pgc-CreERT2/YFP) mice. Gastric tissues were collected, followed by lineage-tracing experiments and histologic and immunofluorescence staining. We further established Pgc-CreERT2;KrasG12D/+ mice and investigated whether PGC transcript-expressing cells are responsible for the precancerous state in gastric glands. To investigate cancer development from PGC transcript-expressing cells with activated Kras, inactivated Apc, and Trp53 signaling pathways, we crossed Pgc-CreERT2/+ mice with conditional KrasG12D, Apcflox, Trp53flox mice. RESULTS: Expectedly, mCherry mainly labeled chief cells in the Pgc-CreERT2 mice. However, mCherry was also detected throughout the neck cell and isthmal stem/progenitor regions, albeit at lower levels. In the Pgc-CreERT2;KrasG12D/+ mice, PGC transcript-expressing cells with KrasG12D/+ mutation presented pseudopyloric metaplasia. The early induction of proliferation at the isthmus may reflect the ability of isthmal progenitors to react rapidly to Pgc-driven KrasG12D/+ oncogenic mutation. Furthermore, Pgc-CreERT2;KrasG12D/+;Apcflox/flox mice presented intramucosal dysplasia/carcinoma and Pgc-CreERT2;KrasG12D/+;Apcflox/flox;Trp53flox/flox mice presented invasive and metastatic gastric carcinoma. CONCLUSIONS: The Pgc-CreERT2 knock-in mouse is an invaluable tool to study the effects of successive oncogenic activation in the mouse corpus. Time-course observations can be made regarding the responses of isthmal and chief cells to oncogenic insults. We can observe stomach-specific tumorigenesis from the beginning to metastatic development.
引用
- Douchi D, Yamamura A, Matsuo J, et al. Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. Gastroenterology. 2021. PMID: 34391772. doi:10.1053/j.gastro.2021.08.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。